A BBC investigation has found that two life-saving drugs used to treat Covid-19 patients in India – remdesivir and tocilizumab – are in short supply and being sold for excessive rates on a thriving black market. Vikas Pandey reports from the capital Delhi.
Abhinav Sharma’s uncle had very high fever and difficulty breathing when he was admitted to a hospital in Delhi.
He tested positive for coronavirus and doctors told the family to get remdesivir – an antiviral drug that’s been approved in India for clinical trial and also under “emergency use authorisation”, meaning doctors can prescribe it on compassionate grounds.
But procuring it proved an impossible task – remdesivir did not seem to be available anywhere.
Mr Sharma desperately called people to arrange for the drug as